[fcb5af]: / literature / by_gene / MSH6.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 32782434 10.1186/s12935-020-01457-8 2022 Evaluation of the upregulation and surface expression of hypoxanthine guanine phosphoribosyltransferase in acute lymphoblastic leukemia and Burkitt's B cell lymphoma. MSH6
2 33811277 10.1007/s10689-021-00244-2 2022 Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma. MSH6
3 33928678 10.1111/den.14004 2022 Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors. MSH6
4 34538134 10.1177/03009858211022704 2022 Mismatch repair deficiency in canine neoplasms. MSH6
5 34787334 10.1111/pde.14861 2022 Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD). MSH6
6 35227120 10.1177/10935266221075605 2022 Diffuse Large B-Cell Lymphoma, Epstein-Barr Virus -Positive Kappa Monotypic Plasma Cell Proliferation and Invasive Carcinoma, Developing in a Child With Defective Mismatch Repair. MSH6
7 35359413 10.3389/fonc.2022.817635 2022 Analysis of Genetic Alterations in Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma With Whole-Exome Sequencing. MSH6
8 35812033 10.1136/flgastro-2022-102123 2022 Diagnosis and management of Lynch syndrome. MSH6
9 36097110 10.1007/s11033-022-07761-y 2022 Looking beyond the cytogenetics in haematological malignancies: decoding the role of tandem repeats in DNA repair genes. MSH6
10 32022486 10.1002/cam4.2870 2021 Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B-cell lymphoma. MSH6
11 32866816 10.1016/j.jns.2020.117102 2021 Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment. MSH6
12 34086170 10.1007/s10549-021-06258-9 2021 Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications. MSH6
13 34425783 10.1186/s12876-021-01902-6 2021 Intensive surveillance endoscopy for multiple gastrointestinal tumors in a patient with constitutional mismatch repair deficiency: case report. MSH6
14 30147880 10.1002/ccr3.1564 2020 Rare compound heterozygous mutations in gene <i>MSH6</i> cause constitutive mismatch repair deficiency syndrome. MSH6
15 30456894 10.1002/jcp.27620 2020 Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63. MSH6
16 31697823 10.1182/blood.2019002220 2020 Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. MSH6
17 33143351 10.3390/pathogens9110909 2020 Bovine Leukemia Virus Infection Affects Host Gene Expression Associated with DNA Mismatch Repair. MSH6
18 29449434 10.3324/haematol.2017.176362 2019 MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. MSH6
19 29904176 10.1038/s41431-018-0197-0 2019 Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD). MSH6
20 30551794 10.1016/j.bulcan.2018.10.008 2019 [Constitutional MMR deficiency: Genetic bases and clinical implications]. MSH6
21 30734108 10.1007/s00428-019-02528-6 2019 Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma. MSH6
22 28142295 10.1080/10428194.2017.1283029 2018 Identification of a tumor suppressor network in T-cell leukemia. MSH6
23 28465297 10.1158/1541-7786.MCR-16-0305 2018 Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences. MSH6
24 28728506 10.1080/10245332.2017.1354428 2018 Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics. MSH6
25 28923119 10.1186/s13000-017-0645-0 2018 ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis. MSH6
26 29439113 10.1136/gutjnl-2016-312608 2018 Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. MSH6
27 27017609 10.1007/s10689-016-9894-4 2017 MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation. MSH6
28 28157215 10.1038/bcj.2017.3 2017 Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia. MSH6
29 28562508 10.1097/MPH.0000000000000863 2017 Biallelic PMS2 Mutation and Heterozygous DICER1 Mutation Presenting as Constitutional Mismatch Repair Deficiency With Corpus Callosum Agenesis: Case Report and Review of Literature. MSH6
30 28981733 10.1093/jjco/hyx098 2017 Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy. MSH6
31 25978431 10.1038/bcj.2015.35 2016 NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair. MSH6
32 26004186 10.1016/j.celrep.2015.04.052 2016 The CREB Coactivator CRTC2 Is a Lymphoma Tumor Suppressor that Preserves Genome Integrity through Transcription of DNA Mismatch Repair Genes. MSH6
33 26318770 10.1136/jmedgenet-2015-103299 2016 Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort. MSH6
34 26498208 10.1016/j.mrfmmm.2015.10.001 2016 Microsatellite instability detected in tumor-related genes in C57BL/6J mice with thymic lymphoma induced by N-methyl-N-nitrosourea. MSH6
35 26544533 10.1002/pbc.25818 2016 Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. MSH6
36 26558945 10.1615/critreveukaryotgeneexpr.2015013893 2016 Genes Associated with Human Cancers: Their Expressions, Features, Functions, and Significance. MSH6
37 26599546 10.1371/journal.pone.0139663 2016 Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines. MSH6
38 26743104 10.1016/j.ejmg.2015.12.014 2016 Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome. MSH6
39 24068316 10.1007/s10689-013-9676-1 2015 Diversity of the clinical presentation of the MMR gene biallelic mutations. MSH6
40 24662245 10.1038/ncomms4469 2015 Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. MSH6
41 25431869 10.1055/s-0034-1389905 2015 Constitutional mismatch repair-deficiency and whole-exome sequencing as the means of the rapid detection of the causative MSH6 defect. MSH6
42 22916837 10.3109/10428194.2012.723211 2013 Analysis of microsatellite instability in gastric mucosa-associated lymphoid tissue lymphoma. MSH6
43 23066952 10.3109/10428194.2012.739687 2013 Mutation mismatch repair gene deletions in diffuse large B-cell lymphoma. MSH6
44 23960188 10.1084/jem.20122842 2013 DNA repair genes are selectively mutated in diffuse large B cell lymphomas. MSH6
45 21674763 10.1002/pbc.23217 2012 High-grade brain tumors in siblings with biallelic MSH6 mutations. MSH6
46 22000951 10.1016/j.jcpa.2011.08.009 2012 Widespread mismatch repair expression in feline small intestinal lymphomas. MSH6
47 22083360 10.3791/3573 2012 Assessing somatic hypermutation in Ramos B cells after overexpression or knockdown of specific genes. MSH6
48 22493294 10.1182/blood-2011-10-386862 2012 Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis. MSH6
49 22920205 2012 [Constitutional mismatch repair-deficiency syndrome (CMMR-D) - a case report of a family with biallelic MSH6 mutation]. MSH6
50 20015892 10.3324/haematol.2009.015503 2011 Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation. MSH6
51 20846793 10.1016/j.prp.2010.07.007 2011 Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis. MSH6
52 20934970 10.2353/ajpath.2010.100234 2011 Msh6 protects mature B cells from lymphoma by preserving genomic stability. MSH6
53 21703420 10.1016/j.ajpath.2011.03.045 2011 Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein. MSH6
54 22164924 2011 [Management of hereditary non-polyposis syndrome (Lynch syndrome)]. MSH6
55 20305618 10.1038/modpathol.2010.41 2010 Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. MSH6
56 20567595 10.1371/journal.pone.0011182 2010 MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites. MSH6
57 19194194 10.1097/MPH.0b013e31818b3774 2009 Compound heterozygosity for MSH6 mutations in a pediatric lymphoma patient. MSH6
58 19551857 10.1002/ijc.24681 2009 The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. MSH6
59 17601929 10.1136/jmg.2007.048942 2008 Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. MSH6
60 17851451 10.1038/sj.ejhg.5201923 2008 Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. MSH6
61 18593904 10.1158/0008-5472.CAN-08-0019 2008 Zebrafish with mutations in mismatch repair genes develop neurofibromas and other tumors. MSH6
62 18768390 10.1182/blood-2008-06-165027 2008 Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. MSH6
63 17240451 10.1016/j.molimm.2006.12.006 2007 Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias. MSH6
64 17440981 10.1002/cncr.22697 2007 Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies. MSH6
65 16283678 10.1002/ajmg.a.30998 2006 Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6. MSH6
66 15805259 10.1158/0008-5472.CAN-04-3158 2005 A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy. MSH6
67 16000562 10.1158/1078-0432.CCR-04-2025 2005 A homozygous mutation in MSH6 causes Turcot syndrome. MSH6
68 14762794 10.1053/j.gastro.2003.11.008 2004 Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. MSH6
69 12400605 10.1080/1042819021000002956 2003 Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer. MSH6
70 12538346 10.1093/carcin/24.1.31 2003 Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia. MSH6
71 10498615 1999 Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements. MSH6
72 10500837 10.1007/978-1-4615-4811-9_64 1999 Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow. MSH6
73 10545954 10.1038/15544 1999 HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. MSH6
74 9510473 10.1111/j.1349-7006.1998.tb00476.x 1998 Frameshift mutations of the hMSH6 gene in human leukemia cell lines. MSH6
75 9390556 10.1016/s0092-8674(00)80433-x 1997 Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. MSH6